|  

Covington Associates

Locemia Solutions acquired by Eli Lilly and Company


Covington advised Locemia Solutions on the sale of worldwide rights to Locemia’s intranasal glucagon to Eli Lilly and Company (NYSE:LLY).

Get updates on news, events, and opportunities.